

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.08694001 |
| 2 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.69706389 |
| 3 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.59014146 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.35082449 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.35082449 |
| 6 | negative T cell selection (GO:0043383) | 5.28778611 |
| 7 | regulation of gamma-delta T cell activation (GO:0046643) | 5.15880641 |
| 8 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.13799083 |
| 9 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.95854801 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.83267160 |
| 11 | negative thymic T cell selection (GO:0045060) | 4.82627306 |
| 12 | positive T cell selection (GO:0043368) | 4.66255590 |
| 13 | positive thymic T cell selection (GO:0045059) | 4.64333846 |
| 14 | interferon-gamma production (GO:0032609) | 4.59353292 |
| 15 | B cell receptor signaling pathway (GO:0050853) | 4.47447762 |
| 16 | T cell selection (GO:0045058) | 4.28545068 |
| 17 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.18666573 |
| 18 | positive regulation of B cell differentiation (GO:0045579) | 4.14004764 |
| 19 | regulation of B cell differentiation (GO:0045577) | 4.13633060 |
| 20 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.08753160 |
| 21 | negative regulation of cell killing (GO:0031342) | 4.08753160 |
| 22 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.97621337 |
| 23 | thymic T cell selection (GO:0045061) | 3.96068516 |
| 24 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.91846650 |
| 25 | leukocyte aggregation (GO:0070486) | 3.91797460 |
| 26 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.86733761 |
| 27 | response to interleukin-15 (GO:0070672) | 3.85257520 |
| 28 | T cell migration (GO:0072678) | 3.81734202 |
| 29 | cellular response to interleukin-15 (GO:0071350) | 3.81564037 |
| 30 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.77471251 |
| 31 | negative regulation of T cell mediated immunity (GO:0002710) | 3.76442974 |
| 32 | V(D)J recombination (GO:0033151) | 3.72779468 |
| 33 | T cell receptor signaling pathway (GO:0050852) | 3.72359354 |
| 34 | positive regulation of defense response to virus by host (GO:0002230) | 3.69954393 |
| 35 | T cell homeostasis (GO:0043029) | 3.68063998 |
| 36 | ribosomal small subunit assembly (GO:0000028) | 3.60784735 |
| 37 | regulation of T cell tolerance induction (GO:0002664) | 3.60027431 |
| 38 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.59018329 |
| 39 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.55007047 |
| 40 | * mast cell activation (GO:0045576) | 3.52162589 |
| 41 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.41896144 |
| 42 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.39275652 |
| 43 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.37750674 |
| 44 | lymphocyte homeostasis (GO:0002260) | 3.34014541 |
| 45 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.30324704 |
| 46 | T cell costimulation (GO:0031295) | 3.30268311 |
| 47 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.28625058 |
| 48 | positive regulation of interleukin-2 production (GO:0032743) | 3.28263495 |
| 49 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.26028421 |
| 50 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.24917347 |
| 51 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.24693841 |
| 52 | lymphocyte costimulation (GO:0031294) | 3.24672249 |
| 53 | response to type I interferon (GO:0034340) | 3.22383490 |
| 54 | DNA deamination (GO:0045006) | 3.21811878 |
| 55 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.21596119 |
| 56 | mast cell degranulation (GO:0043303) | 3.20060348 |
| 57 | mast cell activation involved in immune response (GO:0002279) | 3.20060348 |
| 58 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.19438623 |
| 59 | positive regulation of granulocyte differentiation (GO:0030854) | 3.19202865 |
| 60 | cellular response to zinc ion (GO:0071294) | 3.18582831 |
| 61 | regulation of alpha-beta T cell activation (GO:0046634) | 3.18072365 |
| 62 | cellular response to type I interferon (GO:0071357) | 3.17989428 |
| 63 | type I interferon signaling pathway (GO:0060337) | 3.17989428 |
| 64 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.17863130 |
| 65 | defense response to protozoan (GO:0042832) | 3.17814897 |
| 66 | regulation of cell killing (GO:0031341) | 3.16689263 |
| 67 | cytidine deamination (GO:0009972) | 3.16291041 |
| 68 | cytidine metabolic process (GO:0046087) | 3.16291041 |
| 69 | cytidine catabolic process (GO:0006216) | 3.16291041 |
| 70 | regulation of regulatory T cell differentiation (GO:0045589) | 3.15837501 |
| 71 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.15517423 |
| 72 | immunoglobulin mediated immune response (GO:0016064) | 3.12616318 |
| 73 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.09321399 |
| 74 | positive regulation of cell killing (GO:0031343) | 3.09027380 |
| 75 | myeloid dendritic cell activation (GO:0001773) | 3.04607507 |
| 76 | * T cell differentiation (GO:0030217) | 3.04510582 |
| 77 | positive regulation of alpha-beta T cell activation (GO:0046635) | 3.03780169 |
| 78 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.03604894 |
| 79 | mature B cell differentiation (GO:0002335) | 3.03119681 |
| 80 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.02420107 |
| 81 | leukocyte homeostasis (GO:0001776) | 3.02218558 |
| 82 | tolerance induction (GO:0002507) | 3.02098222 |
| 83 | negative regulation of phagocytosis (GO:0050765) | 3.01454970 |
| 84 | regulation of defense response to virus by host (GO:0050691) | 3.01411717 |
| 85 | regulation of T cell mediated immunity (GO:0002709) | 3.00563540 |
| 86 | activated T cell proliferation (GO:0050798) | 2.99900079 |
| 87 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.99604998 |
| 88 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.99604998 |
| 89 | lymph node development (GO:0048535) | 2.98849689 |
| 90 | alpha-beta T cell activation (GO:0046631) | 2.97004076 |
| 91 | response to protozoan (GO:0001562) | 2.96524718 |
| 92 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.96500078 |
| 93 | cellular response to interferon-beta (GO:0035458) | 2.96103915 |
| 94 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.95033022 |
| 95 | positive regulation of isotype switching (GO:0045830) | 2.92618787 |
| 96 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.91964672 |
| 97 | positive regulation of T cell mediated immunity (GO:0002711) | 2.91116598 |
| 98 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.89435058 |
| 99 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.89435058 |
| 100 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.89346108 |
| 101 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.88829909 |
| 102 | NIK/NF-kappaB signaling (GO:0038061) | 2.88135960 |
| 103 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.87330626 |
| 104 | B cell proliferation (GO:0042100) | 2.86756548 |
| 105 | regulation of alpha-beta T cell differentiation (GO:0046637) | 2.86743475 |
| 106 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.86400122 |
| 107 | positive regulation of lymphocyte differentiation (GO:0045621) | 2.85319330 |
| 108 | positive regulation of alpha-beta T cell differentiation (GO:0046638) | 2.85010097 |
| 109 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.83457510 |
| 110 | positive regulation of T cell differentiation (GO:0045582) | 2.81979595 |
| 111 | positive regulation of tolerance induction (GO:0002645) | 2.81836948 |
| 112 | germinal center formation (GO:0002467) | 2.81783798 |
| 113 | B cell homeostasis (GO:0001782) | 2.80746534 |
| 114 | regulation of tolerance induction (GO:0002643) | 2.80230716 |
| 115 | alpha-beta T cell differentiation (GO:0046632) | 2.79877458 |
| 116 | positive regulation of humoral immune response (GO:0002922) | 2.78700464 |
| 117 | Peyers patch development (GO:0048541) | 2.77222562 |
| 118 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.77222562 |
| 119 | B cell mediated immunity (GO:0019724) | 2.75898528 |
| 120 | natural killer cell activation (GO:0030101) | 2.75871007 |
| 121 | positive regulation of B cell activation (GO:0050871) | 2.75845534 |
| 122 | mature B cell differentiation involved in immune response (GO:0002313) | 2.74943452 |
| 123 | regulation of response to interferon-gamma (GO:0060330) | 2.74708746 |
| 124 | positive regulation of immunoglobulin production (GO:0002639) | 2.74257174 |
| 125 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.73733992 |
| 126 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.72117137 |
| 127 | regulation of B cell mediated immunity (GO:0002712) | 2.69963227 |
| 128 | viral transcription (GO:0019083) | 2.69398481 |
| 129 | regulation of B cell proliferation (GO:0030888) | 2.69369503 |
| 130 | regulation of isotype switching (GO:0045191) | 2.68794869 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.23349599 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.17494807 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.16911890 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.47243351 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.32957272 |
| 6 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.39454913 |
| 7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.36355781 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.34723323 |
| 9 | * MYC_22102868_ChIP-Seq_BL_Human | 3.02351507 |
| 10 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.94162055 |
| 11 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.91188394 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.87655698 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.86935660 |
| 14 | * MYB_26560356_Chip-Seq_TH2_Human | 2.84619332 |
| 15 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.80909734 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.77793123 |
| 17 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.73820143 |
| 18 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.72255036 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.59928102 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.48453692 |
| 21 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.40897233 |
| 22 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.37747097 |
| 23 | * MAF_26560356_Chip-Seq_TH1_Human | 2.35254529 |
| 24 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.32602558 |
| 25 | * MYB_26560356_Chip-Seq_TH1_Human | 2.30662842 |
| 26 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.29049555 |
| 27 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.27989497 |
| 28 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.27107305 |
| 29 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.22562964 |
| 30 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.13592580 |
| 31 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.10845105 |
| 32 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.02068131 |
| 33 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97610940 |
| 34 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.92843876 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.90569903 |
| 36 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85605371 |
| 37 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.81323336 |
| 38 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.78792241 |
| 39 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.78663766 |
| 40 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76872244 |
| 41 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.69029777 |
| 42 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.68531957 |
| 43 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.66073953 |
| 44 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.61486307 |
| 45 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.59873471 |
| 46 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.58044161 |
| 47 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57192032 |
| 48 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.54892972 |
| 49 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.54358258 |
| 50 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.54059128 |
| 51 | MAF_26560356_Chip-Seq_TH2_Human | 1.53791385 |
| 52 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.52016088 |
| 53 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.47266294 |
| 54 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.42720210 |
| 55 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.42619352 |
| 56 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.42308858 |
| 57 | SPI1_23127762_ChIP-Seq_K562_Human | 1.36643388 |
| 58 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.32718447 |
| 59 | GATA1_22025678_ChIP-Seq_K562_Human | 1.31184820 |
| 60 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.28809012 |
| 61 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.27719774 |
| 62 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.24359700 |
| 63 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.24088601 |
| 64 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.23640758 |
| 65 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.22578220 |
| 66 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.21685203 |
| 67 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.20593030 |
| 68 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.20166999 |
| 69 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.17095844 |
| 70 | GATA3_26560356_Chip-Seq_TH2_Human | 1.15486103 |
| 71 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.15173393 |
| 72 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.14906788 |
| 73 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.14420582 |
| 74 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12586852 |
| 75 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.11218743 |
| 76 | GATA3_26560356_Chip-Seq_TH1_Human | 1.11125005 |
| 77 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.09893485 |
| 78 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.08647973 |
| 79 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.07320665 |
| 80 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07025463 |
| 81 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.05332116 |
| 82 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04669304 |
| 83 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.03491309 |
| 84 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.02225603 |
| 85 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.01114120 |
| 86 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97111531 |
| 87 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.96363182 |
| 88 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.96224286 |
| 89 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93531653 |
| 90 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93362848 |
| 91 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.93248047 |
| 92 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92550133 |
| 93 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.92325651 |
| 94 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.91374959 |
| 95 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.90768893 |
| 96 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90252753 |
| 97 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.89778581 |
| 98 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.89226741 |
| 99 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.88448949 |
| 100 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87838662 |
| 101 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.87834392 |
| 102 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.87745242 |
| 103 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.87716734 |
| 104 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86000670 |
| 105 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.85476490 |
| 106 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.84781023 |
| 107 | P300_27268052_Chip-Seq_Bcells_Human | 0.84259038 |
| 108 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.82819939 |
| 109 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.82819754 |
| 110 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.81176309 |
| 111 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.80897742 |
| 112 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.80710589 |
| 113 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80669648 |
| 114 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.80124385 |
| 115 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.79346530 |
| 116 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78564502 |
| 117 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.76225761 |
| 118 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.75727124 |
| 119 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.75077900 |
| 120 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.74564190 |
| 121 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.74229494 |
| 122 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.73570316 |
| 123 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.73418801 |
| 124 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.72620921 |
| 125 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.70833748 |
| 126 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.70501803 |
| 127 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.70448152 |
| 128 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.67850240 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.31327569 |
| 2 | MP0005671_abnormal_response_to | 4.19036565 |
| 3 | MP0003763_abnormal_thymus_physiology | 4.07253843 |
| 4 | MP0000685_abnormal_immune_system | 3.49175139 |
| 5 | MP0001800_abnormal_humoral_immune | 3.48564307 |
| 6 | MP0001790_abnormal_immune_system | 3.06751967 |
| 7 | MP0005387_immune_system_phenotype | 3.06751967 |
| 8 | MP0009785_altered_susceptibility_to | 3.05226264 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.93427650 |
| 10 | MP0002166_altered_tumor_susceptibility | 2.92908086 |
| 11 | MP0002452_abnormal_antigen_presenting | 2.92239281 |
| 12 | MP0002396_abnormal_hematopoietic_system | 2.91411882 |
| 13 | MP0002723_abnormal_immune_serum | 2.89015526 |
| 14 | * MP0002420_abnormal_adaptive_immunity | 2.86843564 |
| 15 | * MP0002398_abnormal_bone_marrow | 2.86003168 |
| 16 | * MP0001819_abnormal_immune_cell | 2.83426443 |
| 17 | MP0005025_abnormal_response_to | 2.61239073 |
| 18 | * MP0000716_abnormal_immune_system | 2.51736070 |
| 19 | MP0002006_tumorigenesis | 2.47579088 |
| 20 | * MP0002148_abnormal_hypersensitivity_rea | 2.42550558 |
| 21 | * MP0000689_abnormal_spleen_morphology | 2.37877111 |
| 22 | MP0003436_decreased_susceptibility_to | 2.31753519 |
| 23 | * MP0002722_abnormal_immune_system | 2.31481359 |
| 24 | * MP0000703_abnormal_thymus_morphology | 2.30277404 |
| 25 | MP0009333_abnormal_splenocyte_physiolog | 2.25531467 |
| 26 | MP0002405_respiratory_system_inflammati | 2.20820462 |
| 27 | MP0002419_abnormal_innate_immunity | 2.19203222 |
| 28 | MP0004808_abnormal_hematopoietic_stem | 2.13000968 |
| 29 | * MP0002429_abnormal_blood_cell | 2.11414279 |
| 30 | MP0010155_abnormal_intestine_physiology | 2.04633934 |
| 31 | MP0006082_CNS_inflammation | 2.04480436 |
| 32 | MP0005464_abnormal_platelet_physiology | 2.01743154 |
| 33 | MP0003724_increased_susceptibility_to | 1.95210545 |
| 34 | MP0001853_heart_inflammation | 1.89691801 |
| 35 | MP0004947_skin_inflammation | 1.83464257 |
| 36 | MP0001873_stomach_inflammation | 1.74904760 |
| 37 | MP0010094_abnormal_chromosome_stability | 1.71781430 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.71516035 |
| 39 | MP0002933_joint_inflammation | 1.68282615 |
| 40 | MP0005174_abnormal_tail_pigmentation | 1.68094045 |
| 41 | MP0005075_abnormal_melanosome_morpholog | 1.66236815 |
| 42 | MP0003866_abnormal_defecation | 1.65086843 |
| 43 | MP0002138_abnormal_hepatobiliary_system | 1.60380135 |
| 44 | MP0001545_abnormal_hematopoietic_system | 1.53954824 |
| 45 | MP0005397_hematopoietic_system_phenotyp | 1.53954824 |
| 46 | MP0003303_peritoneal_inflammation | 1.52815275 |
| 47 | MP0002132_abnormal_respiratory_system | 1.52761903 |
| 48 | MP0008057_abnormal_DNA_replication | 1.51143646 |
| 49 | MP0000490_abnormal_crypts_of | 1.47510078 |
| 50 | MP0000465_gastrointestinal_hemorrhage | 1.41470187 |
| 51 | MP0004510_myositis | 1.25229021 |
| 52 | MP0000015_abnormal_ear_pigmentation | 1.24533728 |
| 53 | MP0008007_abnormal_cellular_replicative | 1.23351988 |
| 54 | MP0002095_abnormal_skin_pigmentation | 1.23326081 |
| 55 | MP0002009_preneoplasia | 1.22344770 |
| 56 | MP0008469_abnormal_protein_level | 1.19279317 |
| 57 | MP0005645_abnormal_hypothalamus_physiol | 1.19064493 |
| 58 | MP0002019_abnormal_tumor_incidence | 1.18819359 |
| 59 | MP0005310_abnormal_salivary_gland | 1.18706787 |
| 60 | MP0004381_abnormal_hair_follicle | 1.18673452 |
| 61 | MP0003693_abnormal_embryo_hatching | 1.18494325 |
| 62 | MP0008058_abnormal_DNA_repair | 1.18107513 |
| 63 | MP0003300_gastrointestinal_ulcer | 1.15868305 |
| 64 | MP0000858_altered_metastatic_potential | 1.13311174 |
| 65 | MP0003077_abnormal_cell_cycle | 1.12960311 |
| 66 | MP0000372_irregular_coat_pigmentation | 1.08190763 |
| 67 | MP0003045_fibrosis | 1.06979161 |
| 68 | MP0006054_spinal_hemorrhage | 1.05301889 |
| 69 | MP0009278_abnormal_bone_marrow | 1.00355590 |
| 70 | MP0001533_abnormal_skeleton_physiology | 0.99825418 |
| 71 | MP0002163_abnormal_gland_morphology | 0.97785051 |
| 72 | MP0003787_abnormal_imprinting | 0.97178982 |
| 73 | MP0001986_abnormal_taste_sensitivity | 0.95100455 |
| 74 | MP0005409_darkened_coat_color | 0.90749767 |
| 75 | MP0001501_abnormal_sleep_pattern | 0.89117807 |
| 76 | MP0002876_abnormal_thyroid_physiology | 0.87605956 |
| 77 | MP0001919_abnormal_reproductive_system | 0.86511289 |
| 78 | MP0003448_altered_tumor_morphology | 0.85112816 |
| 79 | MP0002693_abnormal_pancreas_physiology | 0.82886002 |
| 80 | MP0008961_abnormal_basal_metabolism | 0.79018023 |
| 81 | MP0002998_abnormal_bone_remodeling | 0.78592302 |
| 82 | MP0003111_abnormal_nucleus_morphology | 0.75279935 |
| 83 | MP0009764_decreased_sensitivity_to | 0.74797081 |
| 84 | MP0008872_abnormal_physiological_respon | 0.72607950 |
| 85 | MP0001851_eye_inflammation | 0.71882718 |
| 86 | MP0002277_abnormal_respiratory_mucosa | 0.69136159 |
| 87 | MP0009763_increased_sensitivity_to | 0.68550001 |
| 88 | MP0004957_abnormal_blastocyst_morpholog | 0.68254656 |
| 89 | MP0000313_abnormal_cell_death | 0.66498493 |
| 90 | MP0003172_abnormal_lysosome_physiology | 0.62894402 |
| 91 | MP0005379_endocrine/exocrine_gland_phen | 0.62789619 |
| 92 | MP0003646_muscle_fatigue | 0.62153952 |
| 93 | MP0010352_gastrointestinal_tract_polyps | 0.61963318 |
| 94 | MP0003828_pulmonary_edema | 0.60391992 |
| 95 | MP0001764_abnormal_homeostasis | 0.59678337 |
| 96 | MP0009765_abnormal_xenobiotic_induced | 0.59497724 |
| 97 | MP0008995_early_reproductive_senescence | 0.58703256 |
| 98 | MP0003943_abnormal_hepatobiliary_system | 0.57988908 |
| 99 | MP0003786_premature_aging | 0.57835658 |
| 100 | MP0002075_abnormal_coat/hair_pigmentati | 0.54424097 |
| 101 | MP0005058_abnormal_lysosome_morphology | 0.53703095 |
| 102 | MP0002136_abnormal_kidney_physiology | 0.53665488 |
| 103 | MP0001348_abnormal_lacrimal_gland | 0.52760262 |
| 104 | MP0003195_calcinosis | 0.52065471 |
| 105 | MP0000477_abnormal_intestine_morphology | 0.51881235 |
| 106 | MP0001191_abnormal_skin_condition | 0.50431411 |
| 107 | MP0000569_abnormal_digit_pigmentation | 0.50297995 |
| 108 | MP0005390_skeleton_phenotype | 0.48962596 |
| 109 | MP0005166_decreased_susceptibility_to | 0.48607408 |
| 110 | MP0001663_abnormal_digestive_system | 0.48374868 |
| 111 | MP0000350_abnormal_cell_proliferation | 0.47455942 |
| 112 | MP0000249_abnormal_blood_vessel | 0.47212898 |
| 113 | MP0000343_altered_response_to | 0.47068309 |
| 114 | MP0003795_abnormal_bone_structure | 0.47032133 |
| 115 | MP0001765_abnormal_ion_homeostasis | 0.47004052 |
| 116 | MP0003191_abnormal_cellular_cholesterol | 0.47001904 |
| 117 | MP0003656_abnormal_erythrocyte_physiolo | 0.46558845 |
| 118 | MP0003252_abnormal_bile_duct | 0.46118668 |
| 119 | MP0005389_reproductive_system_phenotype | 0.44805612 |
| 120 | MP0008873_increased_physiological_sensi | 0.44004003 |
| 121 | MP0008877_abnormal_DNA_methylation | 0.43960232 |
| 122 | MP0003183_abnormal_peptide_metabolism | 0.43656733 |
| 123 | MP0002083_premature_death | 0.43626810 |
| 124 | MP0002928_abnormal_bile_duct | 0.41721289 |
| 125 | MP0000371_diluted_coat_color | 0.41179909 |
| 126 | MP0010307_abnormal_tumor_latency | 0.40668793 |
| 127 | MP0004883_abnormal_blood_vessel | 0.40421897 |
| 128 | MP0001243_abnormal_dermal_layer | 0.40141755 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 5.61663666 |
| 2 | Abnormality of T cell number (HP:0011839) | 5.45637998 |
| 3 | Panhypogammaglobulinemia (HP:0003139) | 5.27898661 |
| 4 | Recurrent viral infections (HP:0004429) | 4.97327015 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.87356323 |
| 6 | B lymphocytopenia (HP:0010976) | 4.83191602 |
| 7 | Abnormality of B cell number (HP:0010975) | 4.83191602 |
| 8 | Severe combined immunodeficiency (HP:0004430) | 4.72566555 |
| 9 | Recurrent bronchitis (HP:0002837) | 4.65298558 |
| 10 | Thyroiditis (HP:0100646) | 4.64756397 |
| 11 | Agammaglobulinemia (HP:0004432) | 4.64234280 |
| 12 | IgM deficiency (HP:0002850) | 4.45678998 |
| 13 | Recurrent fungal infections (HP:0002841) | 4.44211960 |
| 14 | Abnormality of T cells (HP:0002843) | 4.39061191 |
| 15 | Combined immunodeficiency (HP:0005387) | 4.38724348 |
| 16 | IgG deficiency (HP:0004315) | 4.36854499 |
| 17 | Chronic otitis media (HP:0000389) | 4.18844988 |
| 18 | Recurrent abscess formation (HP:0002722) | 4.17250939 |
| 19 | Myositis (HP:0100614) | 4.15223279 |
| 20 | Meningitis (HP:0001287) | 3.94696310 |
| 21 | Eosinophilia (HP:0001880) | 3.86715674 |
| 22 | Recurrent bacterial skin infections (HP:0005406) | 3.79592588 |
| 23 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.77195521 |
| 24 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.70959612 |
| 25 | Recurrent cutaneous fungal infections (HP:0011370) | 3.70959612 |
| 26 | Hypoplasia of the thymus (HP:0000778) | 3.60700724 |
| 27 | Abnormality of eosinophils (HP:0001879) | 3.58883807 |
| 28 | Eczematoid dermatitis (HP:0000976) | 3.56919878 |
| 29 | Lymphopenia (HP:0001888) | 3.55409558 |
| 30 | Recurrent sinusitis (HP:0011108) | 3.51206487 |
| 31 | Granulocytopenia (HP:0001913) | 3.47319485 |
| 32 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.42975069 |
| 33 | Thrombocytosis (HP:0001894) | 3.30389720 |
| 34 | Cellulitis (HP:0100658) | 3.20246239 |
| 35 | Abnormality of T cell physiology (HP:0011840) | 3.19835327 |
| 36 | Gastrointestinal stroma tumor (HP:0100723) | 3.19658705 |
| 37 | Recurrent skin infections (HP:0001581) | 3.17178481 |
| 38 | Vasculitis (HP:0002633) | 3.16032951 |
| 39 | Leukocytosis (HP:0001974) | 3.15904604 |
| 40 | Abnormality of the fingertips (HP:0001211) | 3.14272290 |
| 41 | Inflammation of the large intestine (HP:0002037) | 3.12236711 |
| 42 | Chronic sinusitis (HP:0011109) | 3.08175694 |
| 43 | Stomatitis (HP:0010280) | 3.05364017 |
| 44 | Chronic diarrhea (HP:0002028) | 3.05288519 |
| 45 | Gastrointestinal inflammation (HP:0004386) | 3.04515276 |
| 46 | Pustule (HP:0200039) | 3.03953113 |
| 47 | Mediastinal lymphadenopathy (HP:0100721) | 3.00839502 |
| 48 | Colitis (HP:0002583) | 2.96276183 |
| 49 | Lymphoma (HP:0002665) | 2.93166451 |
| 50 | Autoimmune hemolytic anemia (HP:0001890) | 2.91598927 |
| 51 | Nasal polyposis (HP:0100582) | 2.88763010 |
| 52 | IgA deficiency (HP:0002720) | 2.83929080 |
| 53 | Autoimmune thrombocytopenia (HP:0001973) | 2.81654130 |
| 54 | Stomach cancer (HP:0012126) | 2.76286339 |
| 55 | Encephalitis (HP:0002383) | 2.71867691 |
| 56 | Retrobulbar optic neuritis (HP:0100654) | 2.70294628 |
| 57 | Optic neuritis (HP:0100653) | 2.70294628 |
| 58 | Verrucae (HP:0200043) | 2.66282914 |
| 59 | Papilloma (HP:0012740) | 2.66282914 |
| 60 | Petechiae (HP:0000967) | 2.66014136 |
| 61 | Hypoproteinemia (HP:0003075) | 2.65768648 |
| 62 | Bronchitis (HP:0012387) | 2.60730453 |
| 63 | Obstructive lung disease (HP:0006536) | 2.56966558 |
| 64 | Chronic obstructive pulmonary disease (HP:0006510) | 2.56966558 |
| 65 | Gastrointestinal infarctions (HP:0005244) | 2.56199558 |
| 66 | Prolonged bleeding time (HP:0003010) | 2.46296846 |
| 67 | Abnormality of the nasal mucosa (HP:0000433) | 2.45401954 |
| 68 | Recurrent pneumonia (HP:0006532) | 2.45340024 |
| 69 | Orchitis (HP:0100796) | 2.42739886 |
| 70 | Recurrent lower respiratory tract infections (HP:0002783) | 2.42428794 |
| 71 | Increased IgM level (HP:0003496) | 2.41951482 |
| 72 | Hemoptysis (HP:0002105) | 2.26605545 |
| 73 | Spontaneous hematomas (HP:0007420) | 2.25629442 |
| 74 | Prostate neoplasm (HP:0100787) | 2.25332696 |
| 75 | Abnormality of the prostate (HP:0008775) | 2.24762068 |
| 76 | Pulmonary infiltrates (HP:0002113) | 2.24552396 |
| 77 | Osteomyelitis (HP:0002754) | 2.23803892 |
| 78 | Gangrene (HP:0100758) | 2.21021276 |
| 79 | Epistaxis (HP:0000421) | 2.20895984 |
| 80 | Emphysema (HP:0002097) | 2.20880978 |
| 81 | Reticulocytopenia (HP:0001896) | 2.19587924 |
| 82 | Sepsis (HP:0100806) | 2.19437017 |
| 83 | Abnormality of the pleura (HP:0002103) | 2.19209581 |
| 84 | Hypergammaglobulinemia (HP:0010702) | 2.19008032 |
| 85 | Recurrent otitis media (HP:0000403) | 2.11129492 |
| 86 | Alveolar cell carcinoma (HP:0006519) | 2.10143392 |
| 87 | Amaurosis fugax (HP:0100576) | 2.05910452 |
| 88 | Arterial thrombosis (HP:0004420) | 2.05335761 |
| 89 | Keratoconjunctivitis sicca (HP:0001097) | 2.05096416 |
| 90 | Abnormality of macrophages (HP:0004311) | 2.02401336 |
| 91 | Increased IgE level (HP:0003212) | 2.02217882 |
| 92 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.99086969 |
| 93 | Basal cell carcinoma (HP:0002671) | 1.98926376 |
| 94 | Skin rash (HP:0000988) | 1.97706060 |
| 95 | Abnormal number of erythroid precursors (HP:0012131) | 1.97195824 |
| 96 | Neutropenia (HP:0001875) | 1.96935053 |
| 97 | Pulmonary embolism (HP:0002204) | 1.96539096 |
| 98 | Congenital stationary night blindness (HP:0007642) | 1.95753110 |
| 99 | Gingival bleeding (HP:0000225) | 1.95222590 |
| 100 | Chest pain (HP:0100749) | 1.94616078 |
| 101 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.92719167 |
| 102 | Acute hepatic failure (HP:0006554) | 1.92279911 |
| 103 | Leukopenia (HP:0001882) | 1.91224367 |
| 104 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.91187556 |
| 105 | Abnormality of male internal genitalia (HP:0000022) | 1.90026823 |
| 106 | Joint swelling (HP:0001386) | 1.89026684 |
| 107 | Urticaria (HP:0001025) | 1.88935550 |
| 108 | Skin ulcer (HP:0200042) | 1.88922353 |
| 109 | Anorexia (HP:0002039) | 1.88836667 |
| 110 | Keratitis (HP:0000491) | 1.88334422 |
| 111 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.87436539 |
| 112 | Aplastic anemia (HP:0001915) | 1.87431772 |
| 113 | Acute myeloid leukemia (HP:0004808) | 1.86628568 |
| 114 | Hypochromic anemia (HP:0001931) | 1.84952371 |
| 115 | Keratoconjunctivitis (HP:0001096) | 1.84676045 |
| 116 | Restrictive lung disease (HP:0002091) | 1.81106461 |
| 117 | Pulmonary fibrosis (HP:0002206) | 1.78291674 |
| 118 | Purpura (HP:0000979) | 1.76000956 |
| 119 | Attenuation of retinal blood vessels (HP:0007843) | 1.72075273 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.35079935 |
| 2 | TXK | 4.64333289 |
| 3 | BLK | 2.61372523 |
| 4 | JAK3 | 2.55183491 |
| 5 | ZAP70 | 2.54112298 |
| 6 | KIT | 2.43485319 |
| 7 | IKBKE | 2.34572407 |
| 8 | TYK2 | 2.22941726 |
| 9 | SYK | 2.22575995 |
| 10 | NME2 | 2.20191789 |
| 11 | ITK | 2.19676971 |
| 12 | STK10 | 2.17615100 |
| 13 | MAP3K14 | 2.16723884 |
| 14 | TEC | 2.15657916 |
| 15 | NLK | 2.13278302 |
| 16 | BTK | 2.09158685 |
| 17 | TBK1 | 2.06731336 |
| 18 | MAP3K10 | 2.02069895 |
| 19 | IRAK4 | 1.94119294 |
| 20 | CSF1R | 1.89408370 |
| 21 | GRK6 | 1.83839686 |
| 22 | LCK | 1.76936343 |
| 23 | FRK | 1.71991124 |
| 24 | TGFBR2 | 1.69177639 |
| 25 | CLK1 | 1.68683746 |
| 26 | BMPR2 | 1.60319271 |
| 27 | TESK2 | 1.54382244 |
| 28 | MAP3K13 | 1.54089692 |
| 29 | IKBKB | 1.47986569 |
| 30 | MST4 | 1.43805605 |
| 31 | JAK1 | 1.43465486 |
| 32 | LYN | 1.40623912 |
| 33 | FGFR4 | 1.35468911 |
| 34 | FLT3 | 1.32161401 |
| 35 | HCK | 1.30752388 |
| 36 | CSK | 1.27561807 |
| 37 | CAMKK2 | 1.26089486 |
| 38 | RIPK4 | 1.25157041 |
| 39 | PIM1 | 1.24691681 |
| 40 | EEF2K | 1.22891238 |
| 41 | IRAK1 | 1.19800372 |
| 42 | FGFR3 | 1.13012413 |
| 43 | SIK3 | 1.03713795 |
| 44 | TLK1 | 1.02460776 |
| 45 | RPS6KA4 | 1.00108776 |
| 46 | ADRBK2 | 0.95167678 |
| 47 | PRKCQ | 0.93682784 |
| 48 | MAP2K2 | 0.92429522 |
| 49 | VRK1 | 0.92426274 |
| 50 | FES | 0.90049629 |
| 51 | PIK3CG | 0.87871037 |
| 52 | TAOK3 | 0.87450642 |
| 53 | PRPF4B | 0.87245373 |
| 54 | EPHA3 | 0.84960004 |
| 55 | STK4 | 0.84305813 |
| 56 | CAMKK1 | 0.83497444 |
| 57 | LRRK2 | 0.82704887 |
| 58 | MARK3 | 0.79896288 |
| 59 | KDR | 0.79346555 |
| 60 | BCKDK | 0.77919249 |
| 61 | IRAK3 | 0.77225980 |
| 62 | SIK2 | 0.76718429 |
| 63 | ZAK | 0.76487023 |
| 64 | CHUK | 0.75622302 |
| 65 | MAP4K2 | 0.73300686 |
| 66 | PRKCH | 0.71508667 |
| 67 | ACVR1B | 0.69597612 |
| 68 | YES1 | 0.69357403 |
| 69 | MAP2K3 | 0.64889027 |
| 70 | TNK2 | 0.62881767 |
| 71 | STK16 | 0.62123044 |
| 72 | TGFBR1 | 0.62022839 |
| 73 | CDK4 | 0.61784394 |
| 74 | PIM2 | 0.61289923 |
| 75 | TNIK | 0.59960163 |
| 76 | MAPK7 | 0.58940052 |
| 77 | ERN1 | 0.58849455 |
| 78 | MAP2K6 | 0.58801827 |
| 79 | CDC7 | 0.58058394 |
| 80 | GRK1 | 0.56285155 |
| 81 | EIF2AK3 | 0.56178915 |
| 82 | BRD4 | 0.56142274 |
| 83 | HIPK2 | 0.54842653 |
| 84 | JAK2 | 0.53596984 |
| 85 | ATR | 0.53566341 |
| 86 | MAPK11 | 0.53328102 |
| 87 | MAP3K11 | 0.52947880 |
| 88 | MAPK4 | 0.50007425 |
| 89 | RPS6KB2 | 0.47812487 |
| 90 | GRK7 | 0.47504506 |
| 91 | NUAK1 | 0.47124882 |
| 92 | PINK1 | 0.46464715 |
| 93 | MATK | 0.46060738 |
| 94 | CDK19 | 0.45503711 |
| 95 | CDK9 | 0.42678365 |
| 96 | CDK12 | 0.42228060 |
| 97 | NEK9 | 0.42222960 |
| 98 | MAPK12 | 0.41544399 |
| 99 | EIF2AK1 | 0.40953754 |
| 100 | MAP3K7 | 0.39789595 |
| 101 | TSSK6 | 0.38989867 |
| 102 | NEK2 | 0.38425565 |
| 103 | RPS6KA5 | 0.37432986 |
| 104 | DYRK3 | 0.36374672 |
| 105 | MELK | 0.36241622 |
| 106 | PASK | 0.33820560 |
| 107 | ADRBK1 | 0.33013914 |
| 108 | PRKD2 | 0.32908894 |
| 109 | IGF1R | 0.32784982 |
| 110 | SRPK1 | 0.32719806 |
| 111 | MAPK13 | 0.30828961 |
| 112 | MAPK3 | 0.30688150 |
| 113 | PDK1 | 0.30198965 |
| 114 | TRPM7 | 0.29763643 |
| 115 | PRKCD | 0.29532132 |
| 116 | EIF2AK2 | 0.29413271 |
| 117 | FYN | 0.28617246 |
| 118 | ABL1 | 0.28038304 |
| 119 | RPS6KA6 | 0.27955801 |
| 120 | MAP3K12 | 0.26808591 |
| 121 | MAPKAPK2 | 0.25851285 |
| 122 | INSR | 0.25553237 |
| 123 | FGR | 0.22947235 |
| 124 | SCYL2 | 0.22863601 |
| 125 | EGFR | 0.20618942 |
| 126 | TRIM28 | 0.19620446 |
| 127 | CDC42BPA | 0.19083968 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.43575813 |
| 2 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.70182361 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.51731625 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.44034026 |
| 5 | Measles_Homo sapiens_hsa05162 | 2.43957504 |
| 6 | DNA replication_Homo sapiens_hsa03030 | 2.38100211 |
| 7 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.37853787 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.37768851 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.37643279 |
| 10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.30111513 |
| 11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.30015862 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.28550354 |
| 13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.25798043 |
| 14 | Mismatch repair_Homo sapiens_hsa03430 | 2.22982166 |
| 15 | Allograft rejection_Homo sapiens_hsa05330 | 2.17611784 |
| 16 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.09910112 |
| 17 | Leishmaniasis_Homo sapiens_hsa05140 | 2.05052906 |
| 18 | Ribosome_Homo sapiens_hsa03010 | 1.94374082 |
| 19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.82853424 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.81713424 |
| 21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.81650889 |
| 22 | Base excision repair_Homo sapiens_hsa03410 | 1.73920567 |
| 23 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.49570420 |
| 24 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.49560663 |
| 25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.38236677 |
| 26 | Homologous recombination_Homo sapiens_hsa03440 | 1.34634343 |
| 27 | Influenza A_Homo sapiens_hsa05164 | 1.34555160 |
| 28 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.31017079 |
| 29 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.23486508 |
| 30 | Hepatitis B_Homo sapiens_hsa05161 | 1.21576067 |
| 31 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.19485121 |
| 32 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.19157887 |
| 33 | Legionellosis_Homo sapiens_hsa05134 | 1.17206397 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.16041963 |
| 35 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.14553002 |
| 36 | Spliceosome_Homo sapiens_hsa03040 | 1.13277026 |
| 37 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.11564827 |
| 38 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.08386895 |
| 39 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.08261536 |
| 40 | Viral myocarditis_Homo sapiens_hsa05416 | 1.08249567 |
| 41 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.06873378 |
| 42 | Pertussis_Homo sapiens_hsa05133 | 1.05527589 |
| 43 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.05300418 |
| 44 | Shigellosis_Homo sapiens_hsa05131 | 1.03444438 |
| 45 | Tuberculosis_Homo sapiens_hsa05152 | 0.99806394 |
| 46 | Asthma_Homo sapiens_hsa05310 | 0.99074559 |
| 47 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.98806053 |
| 48 | Apoptosis_Homo sapiens_hsa04210 | 0.96147257 |
| 49 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.91841875 |
| 50 | RNA degradation_Homo sapiens_hsa03018 | 0.90669483 |
| 51 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.89995947 |
| 52 | Malaria_Homo sapiens_hsa05144 | 0.87202283 |
| 53 | HTLV-I infection_Homo sapiens_hsa05166 | 0.86890537 |
| 54 | Other glycan degradation_Homo sapiens_hsa00511 | 0.86677000 |
| 55 | Platelet activation_Homo sapiens_hsa04611 | 0.86237626 |
| 56 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.85306214 |
| 57 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.83367386 |
| 58 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.82908605 |
| 59 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.82266727 |
| 60 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.82259979 |
| 61 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.82174961 |
| 62 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.79622014 |
| 63 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.79308697 |
| 64 | RNA polymerase_Homo sapiens_hsa03020 | 0.78532598 |
| 65 | Cell cycle_Homo sapiens_hsa04110 | 0.75606567 |
| 66 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.75147061 |
| 67 | Colorectal cancer_Homo sapiens_hsa05210 | 0.69730193 |
| 68 | Hepatitis C_Homo sapiens_hsa05160 | 0.69256148 |
| 69 | Salmonella infection_Homo sapiens_hsa05132 | 0.68466177 |
| 70 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.67536282 |
| 71 | Phototransduction_Homo sapiens_hsa04744 | 0.66794054 |
| 72 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.64181182 |
| 73 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.60402427 |
| 74 | Basal transcription factors_Homo sapiens_hsa03022 | 0.60123847 |
| 75 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.59832529 |
| 76 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.58917434 |
| 77 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.58872373 |
| 78 | Proteasome_Homo sapiens_hsa03050 | 0.55345648 |
| 79 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.54739437 |
| 80 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.51948907 |
| 81 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.50050725 |
| 82 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.49600022 |
| 83 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.48597048 |
| 84 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.48511260 |
| 85 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.45230785 |
| 86 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.44469878 |
| 87 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.43046551 |
| 88 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.42474360 |
| 89 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.42353199 |
| 90 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.40731880 |
| 91 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.38477536 |
| 92 | RNA transport_Homo sapiens_hsa03013 | 0.38148924 |
| 93 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.37012936 |
| 94 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.37010266 |
| 95 | Olfactory transduction_Homo sapiens_hsa04740 | 0.36961118 |
| 96 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.36845905 |
| 97 | ABC transporters_Homo sapiens_hsa02010 | 0.36576315 |
| 98 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.36283429 |
| 99 | Thyroid cancer_Homo sapiens_hsa05216 | 0.36187323 |
| 100 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.35401703 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.33740132 |
| 102 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.33685578 |
| 103 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.32890934 |
| 104 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.29772020 |
| 105 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.27124729 |
| 106 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.26486145 |
| 107 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.24882064 |
| 108 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.24056637 |
| 109 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.23899198 |
| 110 | Purine metabolism_Homo sapiens_hsa00230 | 0.23593598 |
| 111 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.23561371 |
| 112 | Protein export_Homo sapiens_hsa03060 | 0.23103911 |
| 113 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.22836662 |
| 114 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.22809046 |
| 115 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.22146549 |
| 116 | Lysosome_Homo sapiens_hsa04142 | 0.21530161 |
| 117 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.18936878 |
| 118 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15587166 |
| 119 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.14078965 |
| 120 | Peroxisome_Homo sapiens_hsa04146 | 0.13702027 |
| 121 | Phagosome_Homo sapiens_hsa04145 | 0.12850511 |
| 122 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.12181697 |
| 123 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.11462816 |
| 124 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.09753100 |
| 125 | Insulin resistance_Homo sapiens_hsa04931 | 0.09025875 |
| 126 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.08768054 |

